We are live on ! Find out more
PCA

Peddock Capital Advisors Portfolio holdings

AUM $501M
1-Year Est. Return 29.8%
This Fund
S&P 500
This Quarter Est. Return
+5.05%
1 Year Est. Return
+29.8%
3 Year Est. Return
+104.15%
5 Year Est. Return
+160.2%
10 Year Est. Return
+350.74%
AUM
$199M
AUM Growth
+$4.24M
Cap. Flow
-$4.24M
Cap. Flow %
-2.12%
Top 10 Hldgs %
53.55%
Holding
259
New
7
Increased
31
Reduced
46
Closed
6

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$2.28M
2
AGN
Allergan plc
AGN
+$475K
3
TGT icon
Target
TGT
+$277K
4
SRCL
Stericycle Inc
SRCL
+$272K
5
NVDA icon
NVIDIA
NVDA
+$251K

Sector Composition

Rank Sector Weight
1 Energy 37.66%
2 Technology 9.17%
3 Financials 8.65%
4 Consumer Staples 6.9%
5 Healthcare 6.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MPLX icon
226
MPLX
MPLX
$59.5B
$8K ﹤0.01%
234
EGL
227
DELISTED
Engility Holdings, Inc.
EGL
$8K ﹤0.01%
294
ALDX icon
228
Aldeyra Therapeutics
ALDX
$91.7M
$5K ﹤0.01%
+752
New +$4.95K
MTSI icon
229
MACOM Technology Solutions
MTSI
$20.4B
$5K ﹤0.01%
163
-2,930
-95% -$106K
HSY icon
230
Hershey
HSY
$35.4B
$4K ﹤0.01%
34
JBLU icon
231
JetBlue
JBLU
$1.96B
$4K ﹤0.01%
+200
New +$4.09K
USB icon
232
US Bancorp
USB
$99.6B
$4K ﹤0.01%
74
AGEN
233
Agenus
AGEN
$249M
$3K ﹤0.01%
41
AMAT icon
234
Applied Materials
AMAT
$426B
$3K ﹤0.01%
56
BND icon
235
Vanguard Total Bond Market
BND
$157B
$3K ﹤0.01%
31
IJS icon
236
iShares S&P Small-Cap 600 Value ETF
IJS
$8.11B
$3K ﹤0.01%
36
MCRB icon
237
Seres Therapeutics
MCRB
$48.1M
$3K ﹤0.01%
15
SRPT icon
238
Sarepta Therapeutics
SRPT
$1.66B
$3K ﹤0.01%
54
VCIT icon
239
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.1B
$3K ﹤0.01%
37
+1
+3% +$88
MNDT
240
DELISTED
Mandiant, Inc. Common Stock
MNDT
$3K ﹤0.01%
230
AXON
241
Axon Enterprise
AXON
$40.5B
$2K ﹤0.01%
60
ELV icon
242
Elevance Health
ELV
$81.9B
$2K ﹤0.01%
10
EXPE icon
243
Expedia Group
EXPE
$31.2B
$2K ﹤0.01%
20
TXN icon
244
Texas Instruments
TXN
$255B
$2K ﹤0.01%
18
WATT icon
245
Energous
WATT
$80.3M
0
RDS.A
246
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$2K ﹤0.01%
32
+6
+23% +$378
IDTI
247
DELISTED
Integrated Device Technology I
IDTI
$2K ﹤0.01%
76
BDX icon
248
Becton Dickinson
BDX
$43.1B
$1K ﹤0.01%
7
CLF icon
249
Cleveland-Cliffs
CLF
$6.81B
$1K ﹤0.01%
200
PI icon
250
Impinj
PI
$3.89B
$1K ﹤0.01%
31

Similar funds

Peddock Capital Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Peddock Capital Advisors held 259 positions worth $199M, up 2.2% from $195M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Peddock Capital Advisors's Q4 2017 filing shows 7 new, 31 increased, 46 reduced and 6 closed positions. Its largest new stake was Capri Holdings: 7,975 shares worth $502K. The largest sale was ExxonMobil, an estimated $2.28M.

By sector, the portfolio is most concentrated in Energy at 38% of assets, down from 39% a quarter earlier, followed by Technology and Financials.

  • Peddock Capital Advisors's largest Q4 2017 buy was Capri Holdings: 7,975 shares worth $502K.
  • Peddock Capital Advisors added most to Alaska Air in Q4 2017, an estimated $218K increase.
  • Peddock Capital Advisors's biggest Q4 2017 reduction was ExxonMobil, cutting an estimated $2.28M.
  • Peddock Capital Advisors fully exited PG&E in Q4 2017, selling an estimated $31K.
  • Peddock Capital Advisors's ten largest holdings make up 54% of its $199M portfolio in Q4 2017.
  • Peddock Capital Advisors opened 7 new positions and closed 6 in Q4 2017.
  • Peddock Capital Advisors's portfolio value rose 2.2% quarter-over-quarter to $199M.

Based on Peddock Capital Advisors's 13F filing for Q4 2017, filed 2 Feb 2018.